Terran Biosciences and University of Maryland, Baltimore announce exclusive licensing deal for a portfolio of patents and data supporting novel innovation in the psychedelic therapeutic space
Terran Biosciences, Inc. (“Terran”) has entered into an agreement with the University of Maryland, Baltimore (“UMB”) for a worldwide exclusive license to develop and commercialize a portfolio of UMB’s patents and data to support a novel approach to the treatment of neurological and psychiatric illnesses with psychedelic therapeutics. With this transaction, Terran further expands their […]
